Millions of healthy bacteria colonize our guts from the moment we are born. Changes in the composition and abundance of these commensals affect the entire immune system and can predispose us to a variety of diseases, including intestinal infections, inflammatory and metabolic diseases, and cancer. The gut microbiome interacts not only with the host mucosa but also with potential pathogens; understanding what interactions and pathways are crucial for maintaining homeostasis and protecting the host from harmful bacteria and diseases can open new avenues to developing gut microbiota–based therapeutic approaches. In 'Bench to Bedside', Michael R. Howitt and Wendy S. Garrett examine the importance of metabolic crosstalk between the microbiota and the host in human metabolism and the development of cardiovascular disease. This adds one more layer of complexity to understanding what contributes to this pathology and how to harness the microbiota and their metabolic pathways to prevent it. In 'Bedside to Bench', Nobuhiko Kamada, Grace Chen and Gabriel Núñez discuss how targeting interactions between commensals and bacteria causing intestinal disease can lead to effective therapies to control these infections, which currently seem to lack an adequate treatment. Unraveling how commensals help the host prevent or block colonization of these pathogens can suggest new ways to increase our armamentarium to deal with these sometimes deadly intestinal infections.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Alterations of gut microbiota are associated with blood pressure: a cross-sectional clinical trial in Northwestern China
Journal of Translational Medicine Open Access 30 June 2023
-
Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men – the role of gut microbiota composition: study protocol for the AELC randomized controlled trial
BMC Public Health Open Access 17 January 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sonnenburg, J.L. et al. Science 307, 1955–1959 (2005).
Bäckhed, F. et al. Proc. Natl. Acad. Sci. USA 101, 15718–15723 (2004).
Arumugam, M. et al. Nature 473, 174–180 (2011).
Human Microbiome Project Consortium. Nature 486, 215–221 (2012).
Human Microbiome Project Consortium. Nature 486, 207–214 (2012).
Qin, J. et al. Nature 464, 59–65 (2010).
Turnbaugh, P.J. et al. Nature 444, 1027–1031 (2006).
Vijay-Kumar, M. et al. Science 328, 228–231 (2010).
Henao-Mejia, J. et al. Nature 482, 179–185 (2012).
Hooper, L.V., Littman, D.R. & Macpherson, A.J. Science 336, 1268–1273 (2012).
Dumas, M.-E. et al. Proc. Natl. Acad. Sci. USA 103, 12511–12516 (2006).
Wang, Z. et al. Nature 472, 57–63 (2011).
al-Waiz, M., Mikov, M., Mitchell, S.C. & Smith, R.L. Metabolism 41, 135–136 (1992).
Holmes, E. et al. Sci. Transl. Med. 4, 137rv6 (2012).
Kaddurah-Daouk, R. et al. PLoS ONE 6, e25482 (2011).
Haiser, H.J. & Turnbaugh, P.J. Science 336, 1253–1255 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Howitt, M., Garrett, W. A complex microworld in the gut: Gut microbiota and cardiovascular disease connectivity. Nat Med 18, 1188–1189 (2012). https://doi.org/10.1038/nm.2895
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2895
This article is cited by
-
Alterations of gut microbiota are associated with blood pressure: a cross-sectional clinical trial in Northwestern China
Journal of Translational Medicine (2023)
-
Erhöhte Darmpermeabilität: Pathomechanismus für metabolische Erkrankungen?
Der Diabetologe (2021)
-
Impaired intestinal barrier in patients with obstructive sleep apnea
Sleep and Breathing (2021)
-
Contributions of risk factors and medical care to cardiovascular mortality trends
Nature Reviews Cardiology (2015)
-
Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men – the role of gut microbiota composition: study protocol for the AELC randomized controlled trial
BMC Public Health (2014)